ABT-263 exhibits apoptosis-inducing potential in oral cancer cells by targeting C/EBP-homologous protein

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Cellular Oncology

• Publication date

  2019-03-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s13402-019-00431-5PMID 30919222PMCID PMC12994282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin.

  2018cited by this paper
• Selective targeting of antiapoptotic BCL‐2 proteins in cancer

  2018cited by this paper
• Transcription Factor C/EBP Homologous Protein in Health and Diseases

  2017cited by this paper
• ABT-263 induces G1/G0-phase arrest, apoptosis and autophagy in human esophageal cancer cells in vitro

  2017cited by this paper
• CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy

  2017cited by this paper
• Sorafenib potentiates ABT-737-induced apoptosis in human oral cancer cells.

  2017cited by this paper
• ER Stress via CHOP Pathway is Involved in FK506-Induced Apoptosis in Rat Fibroblasts

  2016cited by this paper
• BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells

  2016cited by this paper
• The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2/Akt/FOXO3a signaling

  2015cited by this paper
• Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer

  2015cited by this paper
• Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside.

  2015cited by this paper
• Endoplasmic reticulum stress associated responses in cancer.

  2014cited by this paper
• Endoplasmic Reticulum Stress and Cancer

  2014cited by this paper
• Gossypol Increases Expression of the Pro-apoptotic BH3-only Protein NOXA through a Novel Mechanism Involving Phospholipase A2, Cytoplasmic Calcium, and Endoplasmic Reticulum Stress*

  2014cited by this paper
• Cell and Molecular Determinants of In Vivo Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts

  2014cited by this paper
• Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

  2013cited by this paper
• The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA

  2013cited by this paper
• The BH3 mimetic S1 induces endoplasmic reticulum stress-associated apoptosis in cisplatin-resistant human ovarian cancer cells although it activates autophagy.

  2013cited by this paper
• Bcl-2 inhibitors: emerging drugs in cancer therapy.

  2012cited by this paper
• Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress

  2011cited by this paper
• Gossypol Induces Death Receptor-5 through Activation of the ROS-ERK-CHOP Pathway and Sensitizes Colon Cancer Cells to TRAIL*

  2010cited by this paper
• Mimicking the BH3 domain to kill cancer cells

  2008cited by this paper
• Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models

  2008cited by this paper
• ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.

  2008cited by this paper
• Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL.

  2007cited by this paper
• Mediators of endoplasmic reticulum stress‐induced apoptosis

  2006cited by this paper
• An inhibitor of Bcl-2 family proteins induces regression of solid tumours

  2005cited by this paper
• Roles of CHOP/GADD153 in endoplasmic reticulum stress

  2004cited by this paper

• Targeting JAK/STAT axis in solid tumors: resolving the therapeutic paradox through upstream suppression and downstream disruption

  2026cites this paper
• DDX3X promotes endoplasmic reticulum protein reprogramming via interaction with ERN1 to amplify cerebral ischemia/reperfusion injury

  2025cites this paper
• MOMP: A critical event in cell death regulation and anticancer treatment.

  2025cites this paper
• Tongguanteng injection exerts anti-osteosarcoma effects through the ER stress-associated IRE1/CHOP pathway

  2024cites this paper
• Evaluation of BH3 mimetics as a combination therapy with irradiation in head and neck squamous cell carcinoma.

  2024cites this paper
• Tongguanteng Injection Inhibits Osteosarcoma Progression via the ER Stress-Linked IRE1/CHOP Pathway

  2023cites this paper
• Decreased TRPM7 alleviates high glucose-induced renal tubular epithelial cell injury by inhibiting the HMGB1/TLR4 signaling pathway

  2023cites this paper
• Repurposing Navitoclax to block SARS‐CoV‐2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein

  2023cites this paper
• Navitoclax mediates Interleukin-3 induced human umbilical vein endothelial cells survival and angiogenesis

  2023cites this paper
• The interaction between ASF1B and TLK1 promotes the malignant progression of low-grade glioma

  2023cites this paper
• Regulated cell death (RCD) in cancer: key pathways and targeted therapies

  2022cites this paper
• Tribbles homolog 3 contributes to high glucose-induced injury in retinal pigment epithelial cells via binding to growth factor receptor-bound 2

  2022cites this paper
• Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge.

  2022cites this paper
• α‐Pinene inhibits the growth of cervical cancer cells through its proapoptotic activity by regulating the miR‐34a‐5p/Bcl‐2 signaling axis

  2022cites this paper
• m6A‐related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma

  2022cites this paper
• The potential value of dequalinium chloride in the treatment of cancer: Focus on malignant glioma

  2021cites this paper
• DDDT_A_284213 1705..1716

  2021cites this paper
• Levels of endoplasmic reticulum stress-related mRNA in peritoneal fluid of patients with endometriosis or gynaecological cancer

  2021cites this paper
• Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax.

  2021cites this paper
• Approaches for Head and Neck Cancer Research – Current Status and the Way Forward

  2021cites this paper
• Combination Therapy of Navitoclax with Chemotherapeutic Agents in Solid Tumors and Blood Cancer: A Review of Current Evidence

  2021cites this paper
• Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1

  2021influential citation
• Synergistic Effects of TW-37 and ABT-263 on Renal Cell Carcinoma Cells

  2021cites this paper
• Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent

  2020influential citation
• A Concise Review on Targeted Therapy for Oral Cancer

  2020cites this paper
• Antitumor effect of TW-37, a BH3 mimetic in human oral cancer

  2019cites this paper